Valeant Increases Proposal For Allergan Merger By About 21% Per Share | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Wednesday, May 28, 2014

Email

Comments

Ocular Surgery News

Valeant Pharmaceuticals has increased its April 22 proposal to acquire Allergan, the company announced in a press release.

All of the following are true of Sjögren Syndrome except:
1. hyaline
2. cholesterol
3. calcium
4. amyloid
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us